UNDERWRITING AGREEMENT BETWEEN BERONI GROUP LIMITED MAXIM GROUP, LLC as Representative of the Several Underwriters BERONI GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2022 • Beroni Group LTD • Pharmaceutical preparations
The undersigned, Beroni Group Limited, a corporation formed under the laws of the Commonwealth of Australia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Beroni Group Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with Maxim Group, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
Employment AgreementEmployment Agreement • December 20th, 2021 • Beroni Group LTD • Pharmaceutical preparations
In order to promote the company’s development better, Party A specially invites Party B as the company’s strategic planning and financing consultant. Party B is responsible for formulating strategic planning and financing plan for the development of Party A’s project. Party B has rich experience in strategic planning and agrees to accept Party A’s invitation to act as the company’s strategic planning and financing consultant.
Capital Operation Financial Consultant and Strategic Cooperation Agreement Party A: Tianjin Beroni Biotechnology Co., Ltd. Party B: Zhejiang Hongwei Investment Co., Ltd. Signing date: May 20, 2019Beroni Group LTD • January 24th, 2022 • Pharmaceutical preparations
Memorandum of Understanding This Memorandum of Understanding was signed by both parties on December 6, 2017 in Tianjin, ChinaBeroni Group LTD • January 24th, 2022 • Pharmaceutical preparations
Share Subscription AgreementShare Subscription Agreement • February 4th, 2022 • Beroni Group LTD • Pharmaceutical preparations
N =the number of Equity Securities to be offered for subscription to the Subscriber. A =the total number of Equity Securities proposed to be issued.
THIS DEED is made on 30 July 2018 BETWEEN:Beroni Group LTD • February 4th, 2022 • Pharmaceutical preparations
ThorGene (Beijing) Medical Technology Co., Ltd. Genetic Testing Service Agreement ThorGene (Beijing) Medical Technology Co., Ltd.Testing Service Agreement • February 4th, 2022 • Beroni Group LTD • Pharmaceutical preparations
Address: A1-2F, Biopharmaceutical Park, No. 88, Technology Innovation Six Street, Economic and Technological Development Zone, Beijing
Shareholders’ AgreementAgreement • February 4th, 2022 • Beroni Group LTD • Pharmaceutical preparations • New South Wales
Cooperation AgreementCooperation Agreement • February 4th, 2022 • Beroni Group LTD • Pharmaceutical preparations
Due to the needs of work, Party A employs Party B to act as the strategic development senior consultant of group company. Both parties reach the following agreement through negotiation and both parties shall jointly abide by and execute it.
